Related Experiment Video
Updated: Jun 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Molecular imaging of cancer: MR spectroscopy and beyond
K Pinker1, A Stadlbauer, W Bogner
1Department of Radiology, Division of Molecular and Gender Imaging, Medical University Vienna, Austria.
Abstract:
Proton magnetic resonance spectroscopic imaging is a non-invasive diagnostic tool for the investigation of cancer metabolism. As an adjunct to morphologic and dynamic magnetic resonance imaging, it is routinely used for the staging, assessment of treatment response, and therapy monitoring in brain, breast, and prostate cancer. Recently, its application was extended to other cancerous diseases, such as malignant soft-tissue tumours, gastrointestinal and gynecological cancers, as well as nodal metastasis. In this review, we discuss the current and evolving clinical applications of proton magnetic resonance spectroscopic imaging. In addition, we will briefly discuss other evolving techniques, such as phosphorus magnetic resonance spectroscopic imaging, sodium imaging and diffusion-weighted imaging in cancer assessment.
Related Concept Videos
Applications Of NMR In Biology
The...
Magnetic Resonance Imaging
Nuclear Magnetic Resonance (NMR): Overview
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
